The risk factor: Nasopharyngeal carcinoma

International Journal of Pharmaceutical and Clinical Research

Volumn 3, Issue 3, 2011, Pages 48-51

  Smerq, James ^a   Sharma, Mukta ^a  

^a Department of Scientific Researches Institute of World Wide Education and Technology ^*  (India)

Author keywords

Nasopharyngeal carcinoma; NPC; Risk factors; Salt preserved fish

Indexed keywords

ANTIBODY TITER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; DIETARY INTAKE; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; FAMILIAL INCIDENCE; FOOD INTAKE; GENETIC VARIABILITY; GENOTYPE; HERBAL MEDICINE; HUMAN; HUMAN LEUKOCYTE ANTIGEN GENE; MEDICAL HISTORY; MOLECULAR EPIDEMIOLOGY; NASOPHARYNX CARCINOMA; NONHUMAN; OCCUPATIONAL EXPOSURE; REVIEW; RISK FACTOR; SMOKING HABIT; TUMOR GENE;

EID: 84857946274     PISSN: None     EISSN: 09751556     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. Cancer incidence in five continents, vol. VIII. IARC scientific publications No. 155. Lyon: IARC; 2002.
2. Vaughan TL, Shapiro JA, Burt RD, et al. Nasopharyngeal cancer in a low-risk population: defining risk factors by histological type. Cancer Epidemiol Biomarkers Prev 1996; 5:587-93.
3. Levine PH, Connelly RR. Epidemiology of nasopharyngeal carcinoma. In: Wittes RE, editor. Head and neck cancer. New York: John Wiley & Sons; 1985. p. 13-34.
4. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 70: Epstein-Barr virus and Kaposi's herpesvirus/human herpesvirus 8. Lyon: IARC Press; 1997.
5. Chen CL, Hsu MM, Hsu HC. Differential expression of EBER1 in nontumor nasopharyngeal biopsies and nontumor component of nasopharyngeal carcinoma. Intervirology 1996; 39:230-5.
6. LD LJ, Boyse EA, Oettgen HF, et al. Precipitating antibody in human serum to an antigen present in cultured Burkitt's lymphoma cells. Proc Natl Acad Sci U S A 1966; 56:1699-704.
7. Henle W, Henle G, Ho HC, et al. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst 1970; 44:225-31.
8. Sawaki S, Sugano H, Hirayama T, Kawamura A Jr. and Tachibana T. Histopathological and immunological studies of nasopharyngeal carcinoma. Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi 1975; 8:73-81.
9. Mutirangura A, Pornthanakasem W, Theamboonlers A, et al. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Clin Cancer Res 1998; 4:665-9.
10. Lo YM, Chan LY, Lo KW, et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999; 59:1188-91.
11. Lin JC, Chen KY, Wang WY, et al. Detection of Epstein-Barr virus DNA the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival. J Clin Oncol 2001; 19:2607-15.
12. Lin JC, Wang WY, Chen KY, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004; 350:2461-70.
13. Nawroz H, Koch W, Anker P, Stroun M, Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996; 2:1035-7.
14. Chan AT, Lo YM, Zee B, et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst 2002; 94:1614-9.
15. Henderson BE, Louie E. Discussion of risk factors for nasopharyngeal carcinoma. IARC Sci Publ 1978; 251-60.
16. Yu MC, Ho JH, Lai SH, Henderson BE. Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res 1986; 46:956-61.
17. Shao YM, Poirier S, Ohshima H, et al. Epstein-Barr virus activation in Raji cells by extracts of preserved food from high risk areas for nasopharyngeal carcinoma. Carcinogenesis 1988; 9:1455-7.
18. Chen CS, Pignatelli B, Malaveille C, et al. Levels of direct-acting mutagens, total N-nitroso compounds in nitrosated fermented fish products, consumed in a high-risk area for gastric cancer in southern China. Mutat Res 1992; 265:211-21.
19. Zhu K, Levine RS, Brann EA, Hall HI, Caplan LS, Gnepp DR. Case-control study evaluating the homogeneity and heterogeneity of risk factors between sinonasal and nasopharyngeal cancers. Int J Cancer 2002; 99:119-23.
20. West S, Hildesheim A, Dosemeci M. Non-viral risk factors for nasopharyngeal carcinoma in the Philippines: results from a casecontrol study. Int J Cancer 1993; 55:722-7.
21. Shanmugaratnam K, Tye CY, Goh EH, Chia KB. Etiological factors in nasopharyngeal carcinoma: a hospital-based, retrospective, case-control, questionnaire study. IARC Sci Publ 1978; 199-212. Yu MC, Mo C-C.
22. Chong W-X, Yeh F-S, Henderson BE. Preserved foods and nasopharyngeal carcinoma: a case-control study in Guangxi, China. Cancer Res 1988; 48:1954-9.
23. Yu MC, Garabrant DH, Huang TB, Henderson BE. Occupational and other non-dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China. Int J Cancer 1990; 45:1033-9.
24. Lin TM, Chen KP, Lin CC, et al. Retrospective study on nasopharyngeal carcinoma. J Natl Cancer Inst 1973; 51:1403-8.
25. Mabuchi K, Bross DS, Kessler II. Cigarette smoking and nasopharyngeal carcinoma. Cancer 1985; 55:2874-6.
26. Shanmugaratnam K, Higginson J. Aetiology of NPC. In: Muir CS, Shanmugaratnam K, editors. Cancer of the nasopharynx. UICC monograph series 1. Munksgaard (Copenhagen, Denmark): Union Internationale Contre le Cancer; 1967. p. 130-4.
27. Henderson BE, Louie E, SooHoo Jing J, Buell P, Gardner MB. Risk factors associated with nasopharyngeal carcinoma. N Engl J Med 1976; 295:1101-6.
28. Furukawa M, Komori T, Ishiguro H, Umeda R. Epstein-Barr virus early antigen induction in nasopharyngeal hybrid cells by Chinese medicinal herbs. Auris Nasus Larynx 1986; 13:101-5.
29. Zeng Y, Zhong JM, Ye SQ, et al. Screening of Epstein-Barr virus early antigen expression inducers from Chinese medicinal herbs and plants. Biomed Environ Sci 1994; 7:50-5.
30. Hildesheim A, West S, DeVeyra E, et al. Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma. Cancer Res 1992; 52:3048-51.
31. Ning JP, Yu MC, Wang QS, Henderson BE. Consumption of salted fish and other risk factors for nasopharyngeal carcinoma (NPC) in Tianjin, a low-risk region for NPC in the People's Republic of China. J Natl Cancer Inst 1990; 82:291-6.
32. Li W, Ray RM, Gao DL, et al. Occupational risk factors for nasopharyngeal cancer among female textile workers in Shanghai, China. Occup Environ Med 2006;63:39-44
33. Liu YH, Du CL, Lin CT, Chan CC, Chen CJ, Wang JD. Increased morbidity from nasopharyngeal carcinoma and chronic pharyngitis or sinusitis among workers at a newspaper printing company. Occup Environ Med 2002; 59:18-22.
34. Yang XR, Diehl S, Pfeiffer R, et al. Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in Taiwan. Cancer Epidemiol Biomarkers Prev 2005; 14:900-5.
35. Xia LW, Liang SX, Jiang JW, Zhou XJ, Li J. Trace element content in drinking water of nasopharyngeal carcinoma patients. Cancer Lett 1988; 41:91-7.
36. Loh KS, Goh BC, Lu J, Hsieh WS, Tan L. Familial nasopharyngeal carcinoma in a cohort of 200 patients. Arch Otolaryngol Head Neck Surg 2006; 132:82-5.
37. Friborg J, Wohlfahrt J, Koch A, Storm H, Olsen OR, Melbye M. Cancer susceptibility in nasopharyngeal carcinoma families-a population-based cohort study. Cancer Res 2005; 65:8567-72.
38. Hildesheim A, Apple RJ, Chen CJ, et al. Association of HLA class I and II alleles and extended haplotypes with nasopharyngeal carcinoma in Taiwan. J Natl Cancer Inst 2002; 94:1780-9.
39. Ioannidis JPA, Gwinn M, Little J, et al. A road map for efficient and reliable human genome epidemiology. Nat Genet 2006; 38:3-5.